Skip to content
Vericel Corporation icon

Vericel Corporation

VCELStocksPharmaceuticals MajorUnited StatesNasdaqUSD

Price

$39.52

Today

+0.6%

YTD

+9.3%

About

Vericel Corp is a recognised name in the biotech and healthcare sector, specialising in promoting advanced therapies that aid patient care. Known for its diligence and innovation, Vericel operates across many international territories, aiming to address serious medical needs worldwide. Vericel engages in the research, development, manufacture and distribution of advanced cell therapies and other treatment services for sports medicine and severe burn care. Its portfolio includes breakthrough products such as MACI and Epicel. Add VCEL stock to your eToro watchlist to monitor the share price changes.

Price chart
Closing price history for VCEL (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)114.91
P/S (TTM)8.17
P/B (TTM)6.73
Market cap$2.40B
Cap tierMid-cap
Industry avg P/E-43.36

Profitability

Gross margin74.84%
EBIT margin5.40%
Net margin-9.21%
ROE6.59%
ROA4.72%

Earnings & Revenue

Revenue (TTM)$292.09M
Revenue growth (1Y)+22.4%
EPS (TTM)$0.41
Free cash flow$47.49M
Total debt$96.42M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.16
Employees398
Next earnings5 Nov '26
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.